• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过尿比重对尿蝶啶进行标准化以早期检测癌症。

Normalization of urinary pteridines by urine specific gravity for early cancer detection.

作者信息

Burton Casey, Shi Honglan, Ma Yinfa

机构信息

Department of Chemistry and Center for Biomedical Science & Engineering, MO University of Science and Technology, Rolla, MO 65409, United States.

Department of Chemistry and Center for Biomedical Science & Engineering, MO University of Science and Technology, Rolla, MO 65409, United States.

出版信息

Clin Chim Acta. 2014 Aug 5;435:42-7. doi: 10.1016/j.cca.2014.04.022. Epub 2014 May 2.

DOI:10.1016/j.cca.2014.04.022
PMID:24792383
Abstract

BACKGROUND

Urinary biomarkers, such as pteridines, require normalization with respect to an individual's hydration status and time since last urination. Conventional creatinine-based corrections are affected by a multitude of patient factors whereas urine specific gravity (USG) is a bulk specimen property that may better resist those same factors. We examined the performance of traditional creatinine adjustments relative to USG to six urinary pteridines in aggressive and benign breast cancers.

METHODS

6-Biopterin, neopterin, pterin, 6-hydroxymethylpterin, isoxanthopterin, xanthopterin, and creatinine were analyzed in 50 urine specimens with a previously developed liquid chromatography-tandem mass spectrometry technique. Creatinine and USG performance were evaluated with non-parametric Mann-Whitney hypothesis testing.

RESULTS

USG and creatinine were moderately correlated (r=0.857) with deviations occurring in dilute and concentrated specimens. In 48 aggressive and benign breast cancers, normalization by USG significantly outperformed creatinine adjustments which marginally outperformed uncorrected pteridines in predicting pathological status. In addition, isoxanthopterin and xanthopterin were significantly higher in pathological specimens when normalized by USG.

CONCLUSION

USG, as a bulk property, can provide better performance over creatinine-based normalizations for urinary pteridines in cancer detection applications.

摘要

背景

尿生物标志物,如蝶啶,需要根据个体的水合状态和上次排尿后的时间进行标准化。传统的基于肌酐的校正受多种患者因素影响,而尿比重(USG)是一种总体标本特性,可能更能抵抗这些相同因素。我们研究了在侵袭性和良性乳腺癌中,相对于USG,传统肌酐校正对六种尿蝶啶的性能。

方法

采用先前开发的液相色谱-串联质谱技术分析了50份尿液标本中的6-生物蝶呤、新蝶呤、蝶呤、6-羟甲基蝶呤、异黄蝶呤、黄蝶呤和肌酐。通过非参数曼-惠特尼假设检验评估肌酐和USG的性能。

结果

USG与肌酐呈中度相关(r=0.857),在稀释和浓缩标本中出现偏差。在48例侵袭性和良性乳腺癌中,在预测病理状态方面,USG标准化显著优于肌酐校正,而肌酐校正略优于未校正的蝶啶。此外,当通过USG标准化时,病理标本中的异黄蝶呤和黄蝶呤显著更高。

结论

在癌症检测应用中,USG作为一种总体特性,在尿蝶啶的基于肌酐的标准化方面比肌酐具有更好的性能。

相似文献

1
Normalization of urinary pteridines by urine specific gravity for early cancer detection.通过尿比重对尿蝶啶进行标准化以早期检测癌症。
Clin Chim Acta. 2014 Aug 5;435:42-7. doi: 10.1016/j.cca.2014.04.022. Epub 2014 May 2.
2
Simultaneous detection of six urinary pteridines and creatinine by high-performance liquid chromatography-tandem mass spectrometry for clinical breast cancer detection.高效液相色谱-串联质谱法同时检测六种尿蝶呤和肌酐用于临床乳腺癌检测。
Anal Chem. 2013 Nov 19;85(22):11137-45. doi: 10.1021/ac403124a. Epub 2013 Nov 4.
3
A rebuttal to "A comment to 'Normalization of urinary pteridines by urine specific gravity for early cancer detection' [Clin. Chim. Acta 435 (2014) 42-47]".对《“通过尿比重对尿蝶啶进行标准化以早期检测癌症”的评论》[《临床化学学报》435 (2014) 42 - 47]的反驳
Clin Chim Acta. 2015 Jan 1;438:415-7. doi: 10.1016/j.cca.2014.08.044. Epub 2014 Sep 19.
4
A comment to "normalization of urinary pteridines by urine specific gravity for early cancer detection" [Clin. Chim. Acta 435 (2014) 42-47].对“通过尿比重对尿蝶啶进行标准化以早期检测癌症”的评论[《临床化学学报》435 (2014) 42 - 47]
Clin Chim Acta. 2015 Jan 1;438:418-9. doi: 10.1016/j.cca.2014.08.032. Epub 2014 Sep 3.
5
Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.尿液代谢物分析为卵巢癌和乳腺癌的早期诊断提供了可能。
Clin Cancer Res. 2010 Dec 1;16(23):5835-41. doi: 10.1158/1078-0432.CCR-10-1434. Epub 2010 Oct 18.
6
Pteridine and tryptophan pathways in children with type 1 diabetes: Isoxanthopterin as an indicator of endothelial dysfunction.儿童 1 型糖尿病中的蝶呤和色氨酸途径:异黄蝶呤作为血管内皮功能障碍的指标。
J Pharm Biomed Anal. 2024 Jun 15;243:116072. doi: 10.1016/j.jpba.2024.116072. Epub 2024 Feb 27.
7
A pilot study to assess if urine specific gravity and urine colour charts are useful indicators of dehydration in acute stroke patients.一项评估尿比重和尿色图表是否可作为急性脑卒中患者脱水有用指标的初步研究。
J Adv Nurs. 2011 Sep;67(9):1976-83. doi: 10.1111/j.1365-2648.2011.05645.x. Epub 2011 Apr 21.
8
Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals.恶性和良性卵巢肿瘤患者与健康个体相比,尿中蝶啶水平的差异。
J Photochem Photobiol B. 2015 Dec;153:191-7. doi: 10.1016/j.jphotobiol.2015.09.019. Epub 2015 Sep 24.
9
Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin, and pterin.肿瘤疾病中蝶啶类物质尿排泄的改变。生物蝶呤、新蝶呤、黄蝶呤和蝶呤的测定。
Clin Chim Acta. 1980 Aug 4;105(2):275-86. doi: 10.1016/0009-8981(80)90470-2.
10
Evaluation of pteridines in patients with different tumors.不同肿瘤患者中蝶啶的评估。
Cancer Detect Prev. 1987;10(1-2):71-9.

引用本文的文献

1
Repeated Low-Level Blast Exposure Alters Urinary and Serum Metabolites.反复低强度爆炸暴露会改变尿液和血清代谢物。
Metabolites. 2023 May 8;13(5):638. doi: 10.3390/metabo13050638.
2
Fabrication of Beta-Barium Borate Sensing Head for Non-Invasive Measurement of Fluidic Concentration Variations.β-硼酸钡传感头的制作用于非侵入式测量流体浓度变化。
Sensors (Basel). 2022 Dec 7;22(24):9566. doi: 10.3390/s22249566.
3
Determination of major and trace element variability in healthy human urine by ICP-QMS and specific gravity normalisation.
采用电感耦合等离子体质谱法(ICP-QMS)及比重归一化法测定健康人尿液中常量和微量元素的变异性。
RSC Adv. 2018 Nov 13;8(66):38022-38035. doi: 10.1039/c8ra06794e. eCollection 2018 Nov 7.
4
Establishing pteridine metabolism in a progressive isogenic breast cancer cell model - part II.建立在一个进行性同源乳腺癌细胞模型中的蝶呤代谢 - 第二部分。
Metabolomics. 2022 Apr 28;18(5):27. doi: 10.1007/s11306-022-01885-9.
5
Establishing pteridine metabolism in a progressive isogenic breast cancer cell model.建立在进行性同源乳腺癌细胞模型中的蝶呤代谢。
Metabolomics. 2021 Dec 17;18(1):2. doi: 10.1007/s11306-021-01861-9.
6
Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review.妇科和乳腺癌患者游离氨基酸的变化:综述
Pharmaceuticals (Basel). 2021 Jul 27;14(8):731. doi: 10.3390/ph14080731.
7
Comparison of Pteridine Normalization Methods in Urine for Detection of Bladder Cancer.尿液中蝶啶标准化方法用于膀胱癌检测的比较
Diagnostics (Basel). 2020 Aug 20;10(9):612. doi: 10.3390/diagnostics10090612.
8
Urinary suPAR: a non-invasive biomarker of infection and tissue inflammation for use in studies of large free-ranging mammals.尿可溶性尿激酶型纤溶酶原激活剂受体:一种用于大型自由放养哺乳动物研究的感染和组织炎症的非侵入性生物标志物。
R Soc Open Sci. 2020 Feb 12;7(2):191825. doi: 10.1098/rsos.191825. eCollection 2020 Feb.
9
Pterins as Diagnostic Markers of Mechanical and Impact-Induced Trauma: A Systematic Review.蝶呤作为机械性和冲击性创伤的诊断标志物:一项系统综述
J Clin Med. 2019 Sep 3;8(9):1383. doi: 10.3390/jcm8091383.
10
Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.黄嘌呤氧化酶在杜氏肌营养不良症中过度活跃。
Free Radic Biol Med. 2018 Dec;129:364-371. doi: 10.1016/j.freeradbiomed.2018.10.404. Epub 2018 Oct 10.